Genomics

Dataset Information

152

Cancer-associated IDH1 promotes growth and resistance to targeted therapies in the absence of mutation


ABSTRACT: Oncogenic mutations in two isocitrate dehydrogenase (IDH)-encoding genes (IDH1 and IDH2) have been identified in acute myelogenous leukemia, low-grade glioma, and secondary glioblastoma (GBM). Our in silico and wet-bench analyses indicate that non-mutated IDH1 mRNA and protein are commonly overexpressed in primary GBM. We show that genetic and pharmacologic inactivation of IDH1 decreases GBM cell growth, promotes a more differentiated tumor cell state, increases apoptosis in response to targeted therapies, and prolongs survival of animal subjects bearing patient-derived xenografts (PDXs). On a molecular level, diminished IDH1 activity results in reduced a-ketoglutarate (aKG) and NADPH production, paralleled by deficient carbon flux from glucose or acetate into lipids, exhaustion of reduced glutathione, increased levels of reactive oxygen species (ROS), and enhanced histone methylation and differentiation marker expression. These findings suggest that IDH1 upregulation represents a common metabolic adaptation by GBM to support macromolecular synthesis, aggressive growth, and therapy resistance. Overall design: H3K4me3 histone modification in 2 patient-derived glioma cell lines with shScramble, or 2 independent shRNAs targeted to IDH1.

INSTRUMENT(S): Illumina NextSeq 500 (Homo sapiens)

SUBMITTER: Elizabeth Thomas Bartom  

PROVIDER: GSE98849 | GEO | 2018-03-13

REPOSITORIES: GEO

altmetric image

Publications


Oncogenic mutations in two isocitrate dehydrogenase (IDH)-encoding genes (IDH1 and IDH2) have been identified in acute myelogenous leukemia, low-grade glioma, and secondary glioblastoma (GBM). Our in silico and wet-bench analyses indicate that non-mutated IDH1 mRNA and protein are commonly overexpressed in primary GBMs. We show that genetic and pharmacologic inactivation of IDH1 decreases GBM cell growth, promotes a more differentiated tumor cell state, increases apoptosis in response to targete  ...[more]

Similar Datasets

2014-05-02 | E-GEOD-54077 | ArrayExpress
| GSE83485 | GEO
2013-11-05 | E-GEOD-45019 | ArrayExpress
| GSE85941 | GEO
2016-06-01 | E-GEOD-77594 | ArrayExpress
2011-11-05 | E-GEOD-30835 | ArrayExpress
| GSE85940 | GEO
| GSE85938 | GEO
2016-06-01 | E-GEOD-77828 | ArrayExpress
2010-12-20 | GSE20395 | GEO